Products

What will AGI do for Aprikalim?

This classification denotes an antihypertensive agent with the molecular formula C12H16N2OS2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 374BH4KVRG, chemically known as 2h-thiopyran-2-carbothioamide, tetrahydro-n-methyl-2-(3-pyridinyl)-, 1-oxide but generally known as aprikalim, which bears US NIH Compound Identifier 3034038. European Medicines Agency schedules Aprikalim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05541MIG. The term APRIKALIM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). APRIKALIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aprikalim under HS 29349990 and SITC 51579. As of Q4 2014, APRIKALIM remains the US FDA Preferred Term for this commodity. Aprikalim bears US NLM identifiers UMLS ID C0209261 and NCI Concept Code C77145. SMILES: CNC(=S)[C@@]1(CCCCS1=O)C2=CN=CC=C2.